Erratum to: COXIBRAIN: results of the prospective, randomised, phase II/III study for the selective COX-2 inhibition in chronic subdural haematoma patients.

Title:: Erratum to: COXIBRAIN: results of the prospective, randomised, phase II/III study for the selective COX-2 inhibition in chronic subdural haematoma patients.
Document type:: Published Erratum; Journal Article; Multicenter Study; Validation Studies
Author(s):: Schaumann, A; Klene, W; Rosenstengel, Chr; Ringel, F; Tüttenberg, J; Vajkoczy, P
Journal title abbreviation:: Acta Neurochir (Wien)
Year:: 2017
Journal volume:: 159
Journal issue:: 1
Pages contribution:: 13
Language:: eng
Fulltext / DOI:: doi:10.1007/s00701-016-3016-9
Pubmed ID:: http://view.ncbi.nlm.nih.gov/pubmed/27830324
Print-ISSN:: 0001-6268
TUM Institution:: Neurochirurgische Klinik und Poliklinik
BibTeX

Occurrences: